TruSpine Technologies (LON: TSP) has made th4e FDA 510k submission for the Cervi-Lok spinal stabilisation device. The FDA will take up to 90 days to make a decision. If clearance is received, then marketing can commence. The medical devices company has limited working capital. The share price soared 111% to 1.9p.
ProBiotix Health (LON: PBX) is appointing Niels Peter Bak as technical project manager. He has nearly three decades experience in the probiotics sector. The share price jumped 77.8% to 8p. That is still well below the 21p placing price in March 2022.
Gunsynd (LON: GUN) is providing funding of £1m in Metals One in return for a 25% stake in Finnaust Mining Northern. This investment is dependent on Metals One joining AIM and the simultaneous acquisition of Finnaust and will be provided in four tranches over 18 months. Gunsynd has sold 440,000 shares in Charger Metals, raising £100,000. It retains 2.54 million shares. Gunsynd will also receive 1.5 million warrants in Metals One. The Gunsynd share price increased by two-fifths to 0.35p.
Ananda Developments (LON: ANA) has launched its first two cannabinoid medicines to the unlicensed market. Three private pain and medical cannabis clinics will offer the products. MRX1 will be used in two double blind randomised control trials run by the University of Edinburgh. The share price improved 5.26% to 0.5p.
Shares in KR1 (LON: KR1) edged up 0.82% to 61.5p after it revealed an investment of $300,000 in Side Protocol as part of a pre-seed funding round. According to KR1, “Side Protocol is a distributed mesh liquidity system that utilises innovative inter-blockchain asset exchange application protocols. Unlike liquidity hubs, Side Protocol aims to decentralise liquidity between diverse blockchain networks in a bridgeless manner while maintaining interconnectivity”.
==========
Fallers
Invinity Energy Systems (LON: IES) is selling a 0.2MWh Invinity VS3 flow battery system to VSUN Energy, a subsidiary of Australian Vanadium Ltd. The system will be used by power provider Horizon Power in Western Australia. There will be a trial to assess how the system works within the regional energy system. The share price declined 3.5% to 48.25p.
